These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 9714337)
1. Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P. Chuman Y; Chen ZS; Seto K; Sumizawa T; Furukawa T; Tani A; Haraguchi M; Niwa K; Yamada K; Aikou T; Akiyama S Cancer Lett; 1998 Jul; 129(1):69-76. PubMed ID: 9714337 [TBL] [Abstract][Full Text] [Related]
2. Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P. Sumizawa T; Chen ZS; Chuman Y; Seto K; Furukawa T; Haraguchi M; Tani A; Shudo N; Akiyama SI Mol Pharmacol; 1997 Mar; 51(3):399-405. PubMed ID: 9058594 [TBL] [Abstract][Full Text] [Related]
3. ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P. Chen ZS; Furukawa T; Sumizawa T; Ono K; Ueda K; Seto K; Akiyama SI Mol Pharmacol; 1999 May; 55(5):921-8. PubMed ID: 10220571 [TBL] [Abstract][Full Text] [Related]
4. Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells. Chen ZS; Mutoh M; Sumizawa T; Furukawa T; Haraguchi M; Tani A; Akiyama S Biochem Biophys Res Commun; 1997 Jul; 236(3):586-90. PubMed ID: 9245693 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P. Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360 [TBL] [Abstract][Full Text] [Related]
6. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter. Chen ZS; Kawabe T; Ono M; Aoki S; Sumizawa T; Furukawa T; Uchiumi T; Wada M; Kuwano M; Akiyama SI Mol Pharmacol; 1999 Dec; 56(6):1219-28. PubMed ID: 10570049 [TBL] [Abstract][Full Text] [Related]
7. PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein. Vanhoefer U; Cao S; Minderman H; Tóth K; Scheper RJ; Slovak ML; Rustum YM Clin Cancer Res; 1996 Feb; 2(2):369-77. PubMed ID: 9816180 [TBL] [Abstract][Full Text] [Related]
8. Two pyridine analogues with more effective ability to reverse multidrug resistance and with lower calcium channel blocking activity than their dihydropyridine counterparts. Shudo N; Mizoguchi T; Kiyosue T; Arita M; Yoshimura A; Seto K; Sakoda R; Akiyama S Cancer Res; 1990 May; 50(10):3055-61. PubMed ID: 1970752 [TBL] [Abstract][Full Text] [Related]
9. Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells. Kitazono M; Okumura H; Ikeda R; Sumizawa T; Furukawa T; Nagayama S; Seto K; Aikou T; Akiyama S Int J Cancer; 2001 Jan; 91(1):126-31. PubMed ID: 11149411 [TBL] [Abstract][Full Text] [Related]
10. Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function. Chen ZS; Aoki S; Komatsu M; Ueda K; Sumizawa T; Furukawa T; Okumura H; Ren XQ; Belinsky MG; Lee K; Kruh GD; Kobayashi M; Akiyama S Int J Cancer; 2001 Jul; 93(1):107-13. PubMed ID: 11391629 [TBL] [Abstract][Full Text] [Related]
11. Increased sensitivity to vincristine of MDR cells by the leukotriene D4 receptor antagonist, ONO-1078. Nagayama S; Chen ZS; Kitazono M; Takebayashi Y; Niwa K; Yamada K; Tani A; Haraguchi M; Sumizawa T; Furukawa T; Aikou T; Akiyama S Cancer Lett; 1998 Aug; 130(1-2):175-82. PubMed ID: 9751271 [TBL] [Abstract][Full Text] [Related]
12. Non-P-glycoprotein-mediated multidrug-resistant human KB cells selected in medium containing adriamycin, cepharanthine, and mezerein. Sumizawa T; Chuman Y; Sakamoto H; Iemura K; Almquist KC; Deeley RG; Cole SP; Akiyama S Somat Cell Mol Genet; 1994 Sep; 20(5):423-35. PubMed ID: 7825064 [TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. Loe DW; Almquist KC; Deeley RG; Cole SP J Biol Chem; 1996 Apr; 271(16):9675-82. PubMed ID: 8621643 [TBL] [Abstract][Full Text] [Related]
14. [Mechanisms for resistance to anticancer agents and the reversal of the resistance]. Akiyama S; Chen ZS; Kitazono M; Sumizawa T; Furukawa T; Aikou T Hum Cell; 1999 Sep; 12(3):95-102. PubMed ID: 10695015 [TBL] [Abstract][Full Text] [Related]
15. SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance. Barancík M; Bohácová V; Kvackajová J; Hudecová S; Krizanová O; Breier A Eur J Pharm Sci; 2001 Aug; 14(1):29-36. PubMed ID: 11457647 [TBL] [Abstract][Full Text] [Related]
16. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein. Liu Z; Zhu H; Qu S; Tang L; Cao L; Yu W; Yang X; Jiang S; Zhu D; Tan C; Yu L Anticancer Agents Med Chem; 2018; 18(2):286-294. PubMed ID: 28782465 [TBL] [Abstract][Full Text] [Related]
17. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors. Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155 [TBL] [Abstract][Full Text] [Related]
18. Characterization of H+-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells. Benderra Z; Morjani H; Trussardi A; Manfait M Leukemia; 1998 Oct; 12(10):1539-44. PubMed ID: 9766497 [TBL] [Abstract][Full Text] [Related]
19. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Zaman GJ; Lankelma J; van Tellingen O; Beijnen J; Dekker H; Paulusma C; Oude Elferink RP; Baas F; Borst P Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7690-4. PubMed ID: 7644478 [TBL] [Abstract][Full Text] [Related]
20. An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells. Chen ZS; Mutoh M; Sumizawa T; Furukawa T; Haraguchi M; Tani A; Saijo N; Kondo T; Akiyama S Exp Cell Res; 1998 May; 240(2):312-20. PubMed ID: 9597004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]